We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
MarketAxess Holdings
MKTX
$5.79B
| $195K | ﹤0.01% |
871
+349
| +67% | +$76.7K |
2022 Q1
13 quarters
|
|
1502
Zimmer Biomet
ZBH
$17.4B
| $194K | ﹤0.01% |
2,132
+1,202
| +129% | +$116K |
2013 Q2
48 quarters
|
|
1503
Monro
MNRO
$422M
| $194K | ﹤0.01% |
12,988
-42,205
| -76% | -$608K |
2024 Q1
5 quarters
|
|
1504
Northwest Bancshares
NWBI
$2.14B
| $191K | ﹤0.01% |
14,971
+11,761
| +366% | +$143K |
2025 Q1
1 quarter
|
|
1505
KeyCorp
KEY
$20.9B
| $186K | ﹤0.01% |
+10,660
| New | +$165K |
2025 Q2
0 quarters
|
|
1506
AnaptysBio
ANAB
$1.4B
| $184K | ﹤0.01% |
8,274
| – | – |
2017 Q1
33 quarters
|
|
1507
The Marzetti Company
MZTI
$2.75B
| $183K | ﹤0.01% |
1,061
-834
| -44% | -$144K |
2013 Q2
48 quarters
|
|
1508
Ametek
AME
$57.1B
| $182K | ﹤0.01% |
1,005
-12
| -1% | -$2.06K |
2013 Q2
48 quarters
|
|
1509
AbCellera Biologics
ABCL
$4.04B
| $182K | ﹤0.01% |
53,000
-894,751
| -94% | -$2.23M |
2020 Q4
18 quarters
|
|
1510
First Citizens BancShares
FCNCA
$23.1B
| $180K | ﹤0.01% |
92
+28
| +44% | +$50.8K |
2023 Q2
8 quarters
|
|
1511
IPG Photonics
IPGP
$3.18B
| $177K | ﹤0.01% |
2,583
-2,115
| -45% | -$132K |
2022 Q1
13 quarters
|
|
1512
Corning
GLW
$126B
| $176K | ﹤0.01% |
3,354
-34
| -1% | -$1.59K |
2013 Q2
48 quarters
|
|
1513
Clearway Energy Class C
CWEN
$3.63B
| $176K | ﹤0.01% |
5,489
-430
| -7% | -$12.8K |
2023 Q2
8 quarters
|
|
1514
Columbia Sportswear
COLM
$2.91B
| $175K | ﹤0.01% |
2,862
-2,379
| -45% | -$153K |
2018 Q2
28 quarters
|
|
1515
Chagee Holdings Ltd
CHA
$2.31B
| $172K | ﹤0.01% |
+6,600
| New | +$202K |
2025 Q2
0 quarters
|
|
1516
Expeditors International
EXPD
$25.4B
| $171K | ﹤0.01% |
1,500
-10,785
| -88% | -$1.21M |
2017 Q2
32 quarters
|
|
1517
Charter Communications
CHTR
$11.9B
| $170K | ﹤0.01% |
415
+282
| +212% | +$108K |
2016 Q3
35 quarters
|
|
1518
Franklin Templeton
BEN
$15.6B
| $169K | ﹤0.01% |
+7,098
| New | +$146K |
2025 Q2
0 quarters
|
|
1519
Baker Hughes
BKR
$56B
| $166K | ﹤0.01% |
4,330
-88
| -2% | -$3.32K |
2017 Q4
30 quarters
|
|
1520
NB Bancorp
NBBK
$965M
| $165K | ﹤0.01% |
9,224
-487
| -5% | -$8.22K |
2024 Q3
3 quarters
|
|
1521
ResMed
RMD
$32.9B
| $165K | ﹤0.01% |
638
-7
| -1% | -$1.67K |
2013 Q2
48 quarters
|
|
1522
NuScale Power
SMR
$2.5B
| $163K | ﹤0.01% |
4,111
+3,186
| +344% | +$79.9K |
2024 Q3
3 quarters
|
|
1523
DELISTED
Juniper Networks
JNPR
| $162K | ﹤0.01% |
4,046
-218
| -5% | -$7.81K |
2013 Q2
48 quarters
|
|
1524
Rayonier
RYN
$5.63B
| $161K | ﹤0.01% |
7,597
-1,488
| -16% | -$34K |
2013 Q2
48 quarters
|
|
1525
Air Products & Chemicals
APD
$64.8B
| $160K | ﹤0.01% |
569
-49
| -8% | -$13.4K |
2013 Q2
48 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.